Varenicline Tablet, Film Coated
Product Images NDC 50090-8184

5 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 50090-8184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vareniclinestructure (Vareniclinestructure)

Vareniclinestructure (Vareniclinestructure)
Chemical structure of varenicline tartrate, showing the molecular arrangement of the active ingredient's components.*
FDA Label Image

Vareniclinefigure1 (Vareniclinefigure1)

Vareniclinefigure1 (Vareniclinefigure1)
A bar graph comparing percent values of different treatments across five studies, including Varenicline 0.5 mg BID, Varenicline 1.0 mg BID, Placebo, Varenicline Flexible, Varenicline 1.0 mg BID plus Bupropion SR 150 mg BID, and Bupropion SR 150 mg BID alone. Percentages on the vertical axis range from 0% to 60%, with error bars indicating variability.*
FDA Label Image

Vareniclinefigure2 (Vareniclinefigure2)

Vareniclinefigure2 (Vareniclinefigure2)
A bar chart depicting percentage outcomes from four clinical studies comparing Varenicline 0.5 mg BID and 1.0 mg BID, Varenicline Flexible, and Varenicline 1.0 mg with Bupropion SR 150 mg BID against placebo. Each study section shows distinct bars for each treatment group and placebo, representing comparative effectiveness percentages.*
FDA Label Image

Vareniclinefigure3 (Vareniclinefigure3)

Vareniclinefigure3 (Vareniclinefigure3)
A line graph comparing the percentage of continuous abstinent subjects over nontreatment follow-up weeks for Varenicline 1.0 mg BID versus placebo. The x-axis represents nontreatment follow-up in weeks, while the y-axis shows the percentage of continuous abstinent individuals. The Varenicline group shows a higher abstinence rate over time compared to placebo.*
FDA Label Image

Label Image (Lbl500908184)

Label Image (Lbl500908184)
Label for Varenicline 1 mg film-coated tablets by A-S Medication Solutions. The label states each tablet contains 1.71 mg of varenicline tartrate equivalent to 1 mg of varenicline free base. Storage instructions specify 68 to 77 degrees Fahrenheit. The package contains 56 film-coated tablets and includes a QR code and NDC 50090-8184.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.